Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A multi-component pharmaceutical kit combining **triamcinolone acetonide**, a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive activity; **lidocaine hydrochloride**, a local anesthetic used to provide procedural analgesia; **povidone-iodine**, a topical antiseptic used for skin preparation; and **ammonia**, included as a kit component. In the cited context this combination corresponds to the **Physician EZ Use Joint Tunnel and Trigger Kit**, an unapproved combination product distributed for office-based joint, tunnel, and trigger-point procedures. The pharmacologically central therapeutic component is triamcinolone acetonide, which exerts clinical effects primarily through glucocorticoid receptor agonism for inflammatory and autoimmune conditions and by intra-articular or soft-tissue injection for disorders such as rheumatoid arthritis, bursitis, epicondylitis, tenosynovitis, synovitis of osteoarthritis, and acute gouty arthritis; lidocaine provides local anesthesia and povidone-iodine supports antisepsis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ammonia + triamcinolone acetonide + lidocaine hydrochloride + povidone-iodine.